Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.
about
Molecular and cellular insights into T cell exhaustionNonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesT Follicular Helper Cell-Dependent Clearance of a Persistent Virus Infection Requires T Cell Expression of the Histone Demethylase UTX.NK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infectionHighly individual patterns of virus-immune IgG effector responses in humans.Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.IL-10: A Multifunctional Cytokine in Viral Infections.Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice.B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection.Comparison of methods for phylogenetic B-cell lineage inference using time-resolved antibody repertoire simulations (AbSim).HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells.Sustained T follicular helper cell response is essential for control of chronic viral infection.
P2860
Q26800047-6C9B5785-F737-48AE-8A25-1E587D68B65EQ34057711-98E2ABFD-5EAF-4183-B125-56EA73B664E7Q36515274-6174C4CE-A235-41BC-8891-88CD957F9068Q36608144-7D06562F-9147-47C3-ABAF-AF0662121FE0Q38953491-9FA8C3E4-3132-4F34-AF26-457045B477CAQ39142065-A08EFEF2-A570-4F18-A043-7A7D5B039954Q39186731-911DEDA9-16B6-40E9-A3C5-9A568D2D6794Q39588420-3BFB26F9-7800-4A9B-B9F2-5015913DA5D0Q41935553-66228AFA-D5CB-4F92-A3FB-68760C8E5F9FQ41957699-73D9574C-1017-4312-A5EB-24F03D73B563Q47316818-75D7775F-8CB9-4211-AABB-EFE096268C24Q47399269-24B20664-93AD-48D1-9B60-D079407494BBQ47570502-CCCC61CB-004D-4682-85E7-80608596EC71
P2860
Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Non-neutralizing antibodies pr ...... activating FcγR or complement.
@en
Non-neutralizing antibodies pr ...... activating FcγR or complement.
@nl
type
label
Non-neutralizing antibodies pr ...... activating FcγR or complement.
@en
Non-neutralizing antibodies pr ...... activating FcγR or complement.
@nl
prefLabel
Non-neutralizing antibodies pr ...... activating FcγR or complement.
@en
Non-neutralizing antibodies pr ...... activating FcγR or complement.
@nl
P2860
P356
P1476
Non-neutralizing antibodies pr ...... activating FcγR or complement.
@en
P2093
Kirsten Richter
P2860
P304
P356
10.1002/EJI.201343566
P407
P577
2013-07-15T00:00:00Z